Prediction of response to treatment of chronic hepatitis B with pegylated interferon in the Philippines

Journal of Medical Virology

Volumn 82, Issue 2, 2010, Pages 213-219

  Agdamag, Dorothy M ^a,b   Kageyama, Seiji ^a,c   Leaño, Prisca S ^b   Solante, Rontgene M ^b   Telan, Elizabeth F ^b   Que, Ernesto R ^d   Ichimura, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b San Lazaro Hospital   (Philippines)

^c TOTTORI UNIVERSITY   (Japan)

^d National Kidney Transplant Institute   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; PEGINTERFERON; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PARAMETER; PHILIPPINES; POPULATION DISPERSAL; PROMOTER REGION; SEROCONVERSION; TREATMENT RESPONSE; VIRUS LOAD; VIRUS STRAIN; WILD TYPE;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; FEMALE; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERONS; MALE; MOLECULAR SEQUENCE DATA; PHILIPPINES; POINT MUTATION; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 74549199276     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21549     Document Type: Article

References (25)

1. Buti M, Rodriguez-Frias F, Jardi R, Esteban R. 2005. Hepatitis B virus genome variability and disease progression: The impact of pre-core mutants and HBV genotypes. J Clin Virol 34:S79-S82.
2. Chen MT, Billaud JN, Sallberg M, Guidotti LG, Chisari FV, Jones J, Hughes J, Milich DR. 2004. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc Natl Acad Sci USA 101:14913-14918.
3. Erhardt A, Reineke U, Blondin D, Gerlich WH, Adams O, Heintges T, Niederau C, Haussinger D. 2000. Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B. Hepatology 31:716-725.
4. Friedt M, Gerner P, Lausch E, Trubel H, Zabel B, Wirth S. 1999. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology 29:1252-1258.
5. Hannoun C, KrogsgaardK, HoralP,LindhM. 2002. Genotype mixtures of hepatitis B virus in patients treated with interferon. J Infect Dis 186:752-759.
6. Hou J, Schilling R, Janssen HL, Hansen BE, Heijtink R, Sablon E, Williams R, Lau GK, Schalm SW, Naoumov NV. 2007. Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance. J Med Virol 79:1055-1063.
7. Janssen HL, van Zonneveld M, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, Simon C, So TM, Gerken G, deMan RA, Niesters HG, Zondervan P, Hansen B, Schalm SW. 2005. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: A randomised trial. Lancet 365:123-129.
8. Kanai K, Kako M, Aikawa T, Hino K, Tsubouchi H, Takehira Y, Iwabuchi S, Kawasaki T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M. 1996. Core promoter mutations of hepatitis B virus for the response to interferon in e antigen-positive chronic hepatitis B. Am J Gastroenterol 91:2150-2156.
9. Kramvis A, Kew MC. 1999. The core promoter of hepatitis B virus. J Viral Hepat 6:415-427.
10. Lai CL, Ratziu V, Yuen MF, Poynard T. 2003. Viral hepatitis B. Lancet 362:2089-2094.
11. Lanford RE, Chavez D, Barrera A, Brasky KM. 2003. An infectious clone of woolly monkey hepatitis B virus. J Virol 77:7814-7819.
12. Lau GK, Piratvisuth T, Luo KX, Marcellin P, Thongsawat S, Cooksley G, Gane E, Fried MW, Chow WC, Paik SW, Chang WY, Berg T, Flisiak R, McCloud P, Pluck N. 2005. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med 352:2682-2695.
13. Lau GK, Suri D, Liang R, Rigopoulou EI, Thomas MG, Mullerova I, Nanji A, Yuen ST, Williams R, Naoumov NV. 2002. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology 122:614-624.
14. Marcellin P, Asselah T, Boyer N. 2005. Treatment of chronic hepatitis B. J Viral Hepat 12:333-345.
15. Marrone A, Zampino R, Luongo G, Utili R, Karayiannis P, Ruggiero G. 2003. Low HBeAg serum levels correlate with the presence of the double A1762T/G1764A core promoter mutation and a positive response to interferon in patients with chronic hepatitis B virus infection. Intervirology 46:222-226.
16. Nagasaki F, Niitsuma H, Cervantes JG, Chiba M, Hong S, Ojima T, Ueno Y, Bondoc E, Kobayashi K, Ishii M, Shimosegawa T. 2006. Analysis of the entire nucleotide sequence of hepatitis B virus genotype B in the Philippines reveals a new subgenotype of genotype B. J Gen Virol 87:1175-1180.
17. Perriere G,Gouy M. 1996.WWW-query:An on-line retrieval system for biological sequence banks. Biochimie 78:364-369.
18. Robek MD, Boyd BS, Wieland SF, Chisari FV. 2004. Signal transduction pathways that inhibit hepatitis B virus replication. Proc Natl Acad Sci USA 101:1743-1747.
19. Sakamoto T, Tanaka Y, Orito E, Co J, Clavio J, Sugauchi F, Ito K, Ozasa A, Quino A, Ueda R, Sollano J, Mizokami M. 2006. Novel subtypes (subgenotypes) of hepatitis B virus genotypes B and C among chronic liver disease patients in the Philippines. J Gen Virol 87:1873-1882.
20. Sheldon J, Rodes B, Zoulim F, Bartholomeusz A, Soriano V. 2006. Mutations affecting the replication capacity of the hepatitisBvirus. J Viral Hepat 13:427-434.
21. Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R. 2000. A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness. J Gen Virol 81:67-74.
22. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680.
23. Webster GJ, Reignat S, Brown D, Ogg GS, Jones L, Seneviratne SL, Williams R, Dusheiko G, Bertoletti A. 2004. Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: Implications forimmunotherapy. JVirol 78:5707-5719.
24. Yanase Y, Ohida T, Kaneita Y, Agdamag DM, Leano PS, Gill CJ. 2007. The prevalence of HIV, HBV and HCV among Filipino blood donors and overseas work visa applicants. Bull World Health Organ 85:131-137.
25. Zheng Y, Li J, Ou JH. 2004. Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein. J Virol 78:6908-6914.